Akash M. Bhat BS, Zachary M. Soler MD, MSc, Vinay K. Rathi MD, MBA, Rodney J. Schlosser MD
{"title":"Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries","authors":"Akash M. Bhat BS, Zachary M. Soler MD, MSc, Vinay K. Rathi MD, MBA, Rodney J. Schlosser MD","doi":"10.1002/alr.23362","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Key points</h3>\n \n <div>\n <ul>\n \n <li>CRSwNP-specific mean total annual spending ranged from $5,837 (EDS-FLU) to $28,058 (dupilumab).</li>\n \n <li>Most CRSwNP patients receiving biologics had comorbid asthma and did not undergo sinus surgery.</li>\n \n <li>While biologics were covered by most Medicare Part D plans, only 37% of plans covered EDS-FLU.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":null,"pages":null},"PeriodicalIF":7.2000,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Forum of Allergy & Rhinology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/alr.23362","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Key points
CRSwNP-specific mean total annual spending ranged from $5,837 (EDS-FLU) to $28,058 (dupilumab).
Most CRSwNP patients receiving biologics had comorbid asthma and did not undergo sinus surgery.
While biologics were covered by most Medicare Part D plans, only 37% of plans covered EDS-FLU.
期刊介绍：
International Forum of Allergy & Rhinologyis a peer-reviewed scientific journal, and the Official Journal of the American Rhinologic Society and the American Academy of Otolaryngic Allergy.
International Forum of Allergy Rhinology provides a forum for clinical researchers, basic scientists, clinicians, and others to publish original research and explore controversies in the medical and surgical treatment of patients with otolaryngic allergy, rhinologic, and skull base conditions. The application of current research to the management of otolaryngic allergy, rhinologic, and skull base diseases and the need for further investigation will be highlighted.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
